MBio to Seek FDA Approval for LightDeck® Platform


Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131

Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131
Viewing 1 post (of 1 total)
  • Author
    Posts
  • 04/07/2020 at 1:43 pm #4287

    Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131

    Deprecated: Function seems_utf8 is deprecated since version 6.9.0! Use wp_is_valid_utf8() instead. in /home/cobioscience/www/www/wp-includes/functions.php on line 6131
    Natalie AllenNatalie Allen
    Participant

    Future Use in Outbreak Management Expected, via DARPA Partnership

    Boulder, CO, April 6, 2020 – MBio Diagnostics today announced an expanded scope contract with the US Defense Advanced Research Projects Agency (DARPA), where DARPA will apply additional resources and funds to accelerate progress towards FDA approval for MBio’s LightDeck® platform. Read more in MBio Diagnostic press release.

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.